Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. (Record no. 10277557)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02595 a2200769 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513182555.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199905s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1524-4539 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1161/01.cir.99.18.2371 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Mahaffey, K W |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19990526 |
245 00 - TITLE STATEMENT | |
Title | Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Circulation |
Date of publication, distribution, etc. | May 1999 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2371-7 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Acute Disease |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Age Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Angina, Unstable |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aspirin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Brain Damage, Chronic |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cerebral Hemorrhage |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cerebral Infarction |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cerebrovascular Disorders |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Comorbidity |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diabetes Mellitus |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Electrocardiography |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Eptifibatide |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heart Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heparin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hyperlipidemias |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypertension |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Incidence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Obesity |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Odds Ratio |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Peptides |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Platelet Aggregation Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Platelet Glycoprotein GPIIb-IIIa Complex |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recurrence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Smoking |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Harrington, R A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Simoons, M L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Granger, C B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Graffagnino, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alberts, M J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Laskowitz, D T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Miller, J M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sloan, M A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Berdan, L G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | MacAulay, C M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lincoff, A M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Deckers, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Topol, E J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Califf, R M |
773 0# - HOST ITEM ENTRY | |
Title | Circulation |
Related parts | vol. 99 |
-- | no. 18 |
-- | p. 2371-7 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1161/01.cir.99.18.2371">https://doi.org/10.1161/01.cir.99.18.2371</a> |
Public note | Available from publisher's website |
No items available.